Virtual Conference

Life Science Technical Accounting Update 2026

Dates: Sept 16-17, 2026
CPE Credits: 16
Location: Virtual (PT)
Field of Study: lifesci

Early bird: $545 (through 8/26/2026) · List: $695

The life science industry continues to face rapid change—new ASUs, evolving revenue models, digital transformation, and increasingly complex reporting expectations. The Life Science Technical Accounting Update 2026 is a two-day 16 CPE virtual conference designed to help finance and accounting teams stay ahead of these developments with guidance tailored specifically to biotech, pharma, and med-tech companies. This program goes beyond the standards to focus on real-world application. Sessions will cover select ASUs, practical uses of AI and digital transformation in accounting operations, and the most challenging revenue recognition issues facing life science organizations

LEARNING OBJECTIVES:

Understand the latest accounting updates and ASUs most relevant to life science companies
Identify key timelines, implementation considerations, and factors influencing industry-specific reporting
Gain practical insight into applying AI and digital solutions within life science accounting and finance functions

Schedule

Agenda: DAY 1

Time	Session
8:45–10:10	Life Science Industry Overview Sector Landscape Miodalities and development pathway Business models and capital formation CFO, accounting and tax lens Regulatory and reinforcement Strategic trends Governance and risk
10:10–10:30	Break
10:30–12:00	Gross to Net & Inventory Accounting Gross to Net Introduction and Overview Industry View Estimation Methodology Approaching Launch Key Challenges SEC Comments Close and Financial Reporting GTN Hot Topics Discussion Inventory Accounting Refresh
12:00–12:45	Lunch Break
1:2:45–2:05	Revenue Recognition for Collaboration & License Agreements Analyze key 606 considerations Understand disclosure expectations Practical approached for estimating and constraining variable consideration Review real-world examples
2:05–2:15	Break
2:15–3:30	GenAI Automation Update What works and what doesn’t in corporate accounting Understanding the AI spectrum and AI agents AI in financial reporting & demo Potential impacts to your audit
3:30–3:40	Break
3:40–5:00	Budgeting and Forecasting Best Practices Real life examples of successes and failures Forecast models Leverage different technology approaches

Agenda: DAY 2

Time	Session
8:45–9:55	Tax Update Latest legislative developments Key Tax Proposals Possible timing and other legislative priorities
9:55–10:10	Break
10:10–11:30	Accounting for Financing Arrangements in Life Sciences
11:30–11:45	Break
11:45–1:10	Accounting for R&D and Clinical Trials R&D Funding Arrangements R&D Cost Classifications Other Intangible Assets SEC Comment Letter Trends
1:10–2:00	Lunch Break
2:00–3:15	SEC & FASB Developments Affecting Life Science Companies Disaggregation of income statement expenses Improvements to income tax disclosures SEC Comment Letter trends FASB developments US regulatory updates PCAOB standard-setting and rulemaking activity
3:15–3:30	Break
3:30–4:50	SOX & Internal Controls Update Use of Gen AI Segment Reporting Control Considerations Risk Assessment refresh Deficiencies and severity assessment

Featured Speakers Include

Eugene Bessacini, PwC, Deals Director
Adam Barrow, Riveron, Senior Director
Nick Sanfilippo, Riveron, Director, Accounting Advisory & IPO
Glenn Snyder, Riveron, Senior Director - Interim Management
Zara Muradali, Uncommon Collective, Founder
Matt Norman, Deloitte, Manager
Russ Higgins, Connor Group, Partner
Travis Combs, Riveron, Managing Director
Marcus Lindner, Ernst & Young, Partner
Margaret Smith, Protiviti, Managing Director
Nathaniel Spedalieri, Ernst & Young, Senior Manager
Salonee Hanspal, Ernst & Young, Assurance Senior Manager
Gia Suber, Ernst & Young, Senior - Technical Accounting Advisory Group
Kyle Straub, PwC, Director
Moira Klinger, PwC, Director
Emma Nealis, PwC, Manager
Aleks Zabreyko, Connor Group, Managing Partner
Jeffrey Kummer, Deloitte, Director of Tax Policy
Boyang Zhao, Riveron, Director, Accounting Advisory
Joshua Areola, Ernst & Young, Assurance Senior Manager
Tim Geringer, Ernst & Young, Senior Manager
James Bowie, Ernst & Young, Managing Director, Technical Accounting Advisory Group
Spencer Moses, Ernst & Young, FAAS Manager
Tanner Schnitz, Ernst & Young, Technical Accounting Manager
James Bowie, Ernst & Young, Managing Director, Technical Accounting Advisory Group
Randa Ghantous, Connor Group, Partner
Yachen Suvorov, CFGI, Director
Amanda Smalley, PwC, Partner
Matt Lepley, Connor Group, Partner
Syliva Lin, Deloitte, Senior Manager
Boyan Zhao, Riveron, Director - Technical Accounting & IPO Services
Christie Hutchinson, Riveron, Managing Director, Technical Accounting & IPO
Steve Abrahamson, Ernst & Young, Executive Director
Frank Deluccia, Duff & Phelps, Director
Sean Kennedy, Deloitte, Audit Senior Manager
Alice Chen, Ernst & Young, Senior Manager
Abby Cohen, Deloitte, Audit Senior Manager
Jade Dauser Tepe, Ernst & Young, Corporate Real Estate and Technology Leader
David Nadell, Duff & Phelps, Director
Andrew Debbink, Ernst & Young, Manager
Patrick Hynes, Ernst & Young, Principal
Arlene Mordeno, Ernst & Young, Managing Director
Mark Marcus, Ernst & Young, Senior Manager
Kaetlin Liverman, Deloitte & Touche, Senior Manager
Valerie Vasquez, Deloitte & Touche, Partner